Application potential of induced pluripotent stem cells in the research and treatment of autoimmune diseases (Review)
Molecular Medicine Reports · 2025
DOI: 10.3892/mmr.2025.13698 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Medicine Reports, 2025. Verfasst von Zizhen Ye und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Laboratory, Lucheng District of Wenzhou City Ye Xuanhu Medical Clinic, Wenzhou, Zhejiang 325000, P.R. China. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Autoimmune Diseases. Die Arbeit nennt 175 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Autoimmune diseases are a group of disorders caused by the immune system mistakenly attacking the body's own tissues, including type 1 diabetes, rheumatoid arthritis and multiple sclerosis (MS). These diseases are typically accompanied by chronic inflammation and tissue damage, which markedly impact the quality of life of patients. Induced pluripotent stem cells (iPSCs), owing to their unlimited proliferative capacity and pluripotency, demonstrate unique advantages in the field of regenerative medicine. iPSCs can be induced to differentiate into various functional cells in vitro providing potentially important tools for disease modeling, drug screening and cell therapy. For example, iPSCs can be directed to generate cardiomyocytes, dopaminergic neurons, hepatocyte‑like cells and pancreatic β‑cells, highlighting their broad potential for translational applications. For treating autoimmune diseases, iPSCs can be utilized for tissue repair, replacement therapy and the induction of cells with immunoregulatory functions. The present review summarizes the latest advancements in iPSC technology and its research in various autoimmune diseases, including MS, rheumatoid arthritis, systemic lupus erythematosus, type 1 diabetes and systemic sclerosis. The present study also discusses the main challenges in the application of iPSCs, aiming to provide a theoretical basis and practical guidance for developing novel therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Laboratory, Lucheng District of Wenzhou City Ye Xuanhu Medical Clinic, Wenzhou, Zhejiang 325000, P.R. China.
- Department of Peripheral Vascular Disease, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang 150000, P.R. China.
Zitieren
APA
Ye, Z., Zhao, H., & Ye, X. (2025). Application potential of induced pluripotent stem cells in the research and treatment of autoimmune diseases (Review). Molecular Medicine Reports. https://doi.org/10.3892/mmr.2025.13698
Vancouver
Ye Z, Zhao H, Ye X. Application potential of induced pluripotent stem cells in the research and treatment of autoimmune diseases (Review). Molecular Medicine Reports. 2025. doi:10.3892/mmr.2025.13698
BibTeX
@article{Ye2025,
author = {Ye, Zizhen and Zhao, Hanwei and Ye, Xuanhu},
title = {Application potential of induced pluripotent stem cells in the research and treatment of autoimmune diseases (Review)},
journal = {Molecular Medicine Reports},
year = {2025},
doi = {10.3892/mmr.2025.13698}
}
EUVIMED